Skip to main content
Fig. 3 | Lipids in Health and Disease

Fig. 3

From: Pharmacokinetics and pharmacodynamics of HTD1801 (berberine ursodeoxycholate, BUDCA) in patients with hyperlipidemia

Fig. 3

a Average (+/−SE) plasma berberine concentration-time profiles (linear plot) after single- (day 1) and multiple-dose administration of HTD1801 in the group receiving the highest dose (1000 mg BID). b Average (+/−SE) plasma berberine concentration-time profiles (log-linear plot) after single- (day 1) and multiple-dose administration of HTD1801 in the group receiving the highest dose (1000 mg BID)

Back to article page

Lipids in Health and Disease

ISSN: 1476-511X